Some GLP-1 users report changes in food preferences, often losing their taste for very sweet or fatty foods
A COA is a lab report that supposedly proves the purity and identity of the substance
FAQ What is oral GLP1 therapy for type 2 diabetes
Sussman JB, Kerr EA, Saini SD, et al
Risk of major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality for widely used antihyperglycemic dual and triple therapies for type 2 diabetes management: a cohort study of all Danish users
According to a poll published by Phoenix and Raven last fall, 59 per cent of Canadians were either actively trying to lose weight or planning to, and roughly 40 per cent said they were interested in trying some version of Ozempic